Renal Cancer - Results from #3720

Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study). March 18, 2019

New entities, new technologies, new findings: A review of the cytologic features of recently established subtypes of renal cell carcinoma. March 15, 2019

Gender-specific risk factors for renal cell carcinoma: a systematic review. March 15, 2019

Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP P March 15, 2019

Immune Infiltration in Renal Cell Carcinoma. March 14, 2019

Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma. March 14, 2019

Prognostic indicators of pulmonary metastasis in patients with renal cell carcinoma who have undergone radical nephrectomy. March 14, 2019

Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis. March 13, 2019

Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size. March 13, 2019

Association of ATG7 Polymorphisms and Clear Cell Renal Cell Carcinoma Risk. March 13, 2019

Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database. March 12, 2019

Syntaxin 6: A novel predictive and prognostic biomarker in papillary renal cell carcinoma. March 12, 2019

Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma. March 12, 2019

Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations. March 11, 2019

Identification of mutations associated with acquired resistance to sunitinib in renal cell-cancer. March 11, 2019

The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples. March 11, 2019

Histological complete response with nivolumab for renal cell carcinoma with multiple metastases: A case report. March 8, 2019

TEK is a novel prognostic marker for clear cell renal cell carcinoma. March 8, 2019

Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression. March 8, 2019

Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths. March 7, 2019

Page 187 of 456